Table 3.
Overall survival characteristics of the included studies.
| Surname (year) | Country | Cancer type | Survival analysis | HR statistic | Hazard ratios (95% CI) | Follow-up months | Outcome |
|---|---|---|---|---|---|---|---|
| Tao Yang (2018) | China | Laryngeal cancer | Univariate Multivariate |
Data in paper | 0.389 (0.152, 0.993) | 60 | OS |
| Wei Huang (2016) | China | TSCC | Univariate Multivariate |
Data in paper | 0.476 (0.236, 0.975) | 80 | OS, DFS |
| Fei Tao (2018) | China | Rectal cancer | Univariate Multivariate |
Data in paper | 0.540 (0.350, 0.830) | 96 | OS |
| Peng Jiang (2019) | China | CRC | Univariate Multivariate |
Data in paper | 0.870 (0.787, 0.962) | 72 | OS, DFS |
| Xiaolan Yu (2018) | China | HCC | NA | Survival curves | 0.550 (0.180, 1.670) | 60 | OS |
| Shun Ke (2018) | China | ESCC | Univariate Multivariate |
Data in paper | 0.590 (0.360, 0.950) | 100 | OS, DFS |
| Ronggao Chen (2019) | China | HCC | Univariate Multivariate |
Data in paper | 0.454 (0.251, 0.822) | NA | OS |
TSCC: tongue squamous cell carcinoma; CRC: colorectal cancer; HCC: hepatocellular carcinoma; ESCC: esophageal squamous cell carcinoma; NPC: nasopharyngeal carcinoma; Univariate: univariate analysis; Multivariate: multivariate analysis; NA: not available; OS: overall survival; DFS: disease-free survival.